Market Insights
Growth, Future Prospects, and Competitive Analysis of the Global Immunohistochemistry Market by Products (Antibodies, Equipment, Reagents, and Kits) and Applications (Diagnostics and Drug Testing), 2017-2025
The most common application of immunohistochemistry is to study and identify the site of origin of metastatic tumors when the primary site has already been identified. Technological advancements in the panel of immunostains can be helpful in resolving all diagnostic problems. Recent antibodies such as cadherin-17, SATB2, CDX-2, and violin have found application in the differential diagnosis of suspected metastatic adenocarcinoma. A strong limitation of immunohistochemistry is the number of parameters that can be detected, and the capacity of multiplexing immunohistochemistry is very limited.
For the purpose of this study, the various products studied include antibodies, equipment, reagents, and kits. The applications are classified as diagnostics and drug testing. Antibodies are further classified as primary antibodies and secondary antibodies. Equipment is categorized as (slide staining systems, tissue microarrays, tissue processing systems, slide scanners, and others). Reagents are further sub-segmented as (histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes, and diluents). Diagnostics are further segmented as follows: cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetic Mellitus, and nephrological diseases. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.
Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.
This report also includes qualitative assessmen
Growth, Future Prospects, and Competitive Analysis of the Global Immunohistochemistry Market by Products (Antibodies, Equipment, Reagents, and Kits) and Applications (Diagnostics and Drug Testing), 2017-2025
The most common application of immunohistochemistry is to study and identify the site of origin of metastatic tumors when the primary site has already been identified. Technological advancements in the panel of immunostains can be helpful in resolving all diagnostic problems. Recent antibodies such as cadherin-17, SATB2, CDX-2, and violin have found application in the differential diagnosis of suspected metastatic adenocarcinoma. A strong limitation of immunohistochemistry is the number of parameters that can be detected, and the capacity of multiplexing immunohistochemistry is very limited.
For the purpose of this study, the various products studied include antibodies, equipment, reagents, and kits. The applications are classified as diagnostics and drug testing. Antibodies are further classified as primary antibodies and secondary antibodies. Equipment is categorized as (slide staining systems, tissue microarrays, tissue processing systems, slide scanners, and others). Reagents are further sub-segmented as (histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes, and diluents). Diagnostics are further segmented as follows: cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetic Mellitus, and nephrological diseases. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.
Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global immunohistochemistry market. Market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the global immunohistochemistry market. The key players profiled in this report are Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioSB, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffman La-Roche Ltd., Merck Millipore Corporation, Perkin Elmer, Inc., and Thermo Fisher Scientific, Inc.
Based on product types, the global immunohisto chemistry market is categorized into
Antibodies
- Primary Antibodies
- Secondary Antibodies
Equipment
- slide staining systems
- Tissue Microarrays
- tissue processing systems
- Slide Scanners
- Others
Reagents
- Histological Stains
- Blocking Sera and Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
Factors such as the rising prevalence of cancer, an aging population suffering from chronic diseases, and the urgent need for novel drug discovery in cases such as multiple drug resistance bacterial infection are driving the immunohistochemistry market. In addition, an increasing number of diagnostic centers and increased physician awareness regarding disease etiology will propel deep market penetration for immunohistochemistry. In 2016, the antibodies segment held the largest market share, owing primarily to technological advancements in the production and development of antigen-specific antibodies, which found immense demand in diagnosis and stem cell population determination, among other things, rising demand for personalized medication; and recent technological advancements in biologicals for the treatment of chronic diseases.
Reagents will be the fastest-growing segment throughout the forecast period of 2017–2025, primarily due to factors such as the rising prevalence of chronic diseases, steadily increasing diagnostic centers, and public-private partnerships to combat life-threatening diseases by setting up research and development centers. The major players in the immunohistochemistry market are Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioSB, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffman La-Roche Ltd., Merck Millipore Corporation, Perkin Elmer, Inc., Thermo Fisher Scientific, Inc., and other notable players.
Based on applications, the global immunohisto chemistry market is categorized into
Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
Drug Testing
The crucial application of immunohistochemistry is the use of antibodies to study the tissue distribution of an antigen. Histone proteins are used by eukaryotic cells to store DNA in the form of chromatin material, and antibodies can be used to target histones in order to understand the genetic relationships to chronic diseases. Immunohistochemistry is a comprehensive technique that is employed for the morphological characterization of tumors and other tissue malignancies. In 2016, the diagnostics segment dominated the market mainly due to factors such as the rising prevalence of chronic diseases requiring immediate medical intervention and increasing public health awareness, which resulted in a rising number of diagnostic centers. Furthermore, there has been technological progress in the diagnostic techniques that use antibodies to identify podocalyxin (PODXL), a transmembrane protein involved in cell-cell interaction that is expressed in a variety of cancers, including breast, prostate, testicular, colorectal, and urothelial cancer. The drug testing segment is anticipated to register faster growth throughout the forecast period of 2017–2025, primarily due to the rising incidence of drug-related adverse events and the increasing incidence of multiple drug-resistant bacterial infections.
For the purpose of this study, the global immunohisto chemistry market is categorized into the following regional and country-specific markets:
North America
Europe
- U.K.
- Germany
- France
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- rest of Latin America
Middle East and Africa
- GCC
- Rest of the Middle East and Africa
In the base year 2016, North America was observed to be the largest market for immunohistochemistry. According to the Centers for Disease Control and Prevention, in 2012, about half of the American population suffered from one or more chronic health conditions. The dominance of North America is mainly attributed to the presence of key drivers such as the rising prevalence of chronic disease, a mature biotechnology market, increasing commercialization of immunohistochemistry products, and developed research and healthcare institutions. As per the OECD/European Commission report from 2016, approximately 550,000 premature deaths were reported across the European Union. This factor boosts the demand for antibodies for the identification and screening of biomarkers related to chronic diseases and technological advancements in the tissue processing systems and chromogenic substrates employed for tissue sampling.
Asia Pacific was observed as the fastest-growing regional segment throughout the forecast period of 2017–2025. Factors that are anticipated to propel market growth are the increasing number of geriatric populations suffering from chronic health complications, the competitive nature of the market due to the presence of existing major players and evolving biopharmaceutical manufacturers producing immunohistochemistry reagents and equipment in these regions, and a supportive regulatory environment for immunohistochemistry products. Moreover, factors such as developing health infrastructure and the expansion of research centers by pharmaceutical giants to propel deep market penetration in the untapped market of remote areas with unmet medical needs are going to fuel the rapid growth of the immunohistochemistry market in Latin America, the Middle East, and Africa in the near future.
